Last updated: August 21, 2024
Sponsor: University of Virginia
Overall Status: Completed
Phase
4
Condition
Breast Reconstruction
Pain
Chronic Pain
Treatment
Liposomal bupivacaine TAP block
Bupivacain
Clinical Study ID
NCT04777591
HSR210033
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All female patients who are 18 years or older who will undergo unilateral orbilateral abdomen-based free flap breast reconstruction at UVA Medical Center
Exclusion
Exclusion Criteria:
Subjects with ages <18 years
Allergy to local anesthetic
Inability to tolerate standard postoperative pain management regimen (Tylenol,Toradol, and Oxycodone PRN) for any reason
Subjects who cannot read or understand English
Subjects who are pregnant
Study Design
Total Participants: 117
Treatment Group(s): 2
Primary Treatment: Liposomal bupivacaine TAP block
Phase: 4
Study Start date:
March 01, 2021
Estimated Completion Date:
December 28, 2022
Connect with a study center
University of Virginia
Charlottesville, Virginia 22903
United StatesSite Not Available
University of Virginia Medical Center
Charlottesville, Virginia 22902
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.